Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2022

BillFederalSenateIn Committee
Ending the Diagnostic Odyssey Act of 2021
About This Bill
Committee
Latest Action · June 10, 2021
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)
Congress
117th (2021–2023)
Introduced
June 10, 2021
Cosponsors (3)
3D 0R
View PDF ↗

Summary

Highlight any text to annotate
Ending the Diagnostic Odyssey Act of 2021 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.